CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishFERRERO, Dario
Risultati 1 - 20 di 127 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Very Elderly Patients with Chronic Phase-Chronic Myeloid Leukemia on Imatinib: No Impact of Concomitant Drugs on Complete Cytogenetic Response | 2015 | Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Cattaneo, D; Fava, C; Gozzini, A; Annunziata, M; Tiribelli, M; Pregno, P; Stagno, F; Vigneri, P; Cavazzini, F; Binotto, G; Mansueto, G; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Gasbarrino, C; D'Addosio, A; Cortesi, L; Cedrone, M; Rossi, Ar; Avanzini, P; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Rege-Cambrin, G; Sica, S; Luciano, L; Orlandi, Em; Bocchia, M; Tettamanti, M; Alimena, G; Saglio, G; Rosti, G; Nobili, A; Mannucci, Pm; Cortelezzi, A |
| 2 | VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY? | 2015 | Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A |
| 3 | [Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment] | 1991 | BARONI A ;AIROLDI G ;AGLIATA S ;FORTINA F ;RAGAZZONI E ;CAVAGNINO A ;DE NIGRIS A ;CAMETTI G ;FERRERO D ;FORTINA A |
| 4 | The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib | 2018 | Crisà, Elena; Cilloni, Daniela; Elli, Elena M.; Martinelli, Vincenzo; Palumbo, Giuseppe A.; Pugliese, Novella; Beggiato, Eloise; Frairia, Chiara; Cerrano, Marco; Lanzarone, Giuseppe; Marchetti, Monia; Mezzabotta, Mauro; Boccadoro, Mario; Ferrero, Dario |
| 5 | TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS | 2016 | Fava, C; Rege-Cambrin, G; Dogliotti, I; Berchialla, P; Abruzzese, E; Annunziata, M; Avanzini, P; Bergamaschi, M; Bocchia, M; Caocci, G; Catania, G; Cattaneo, D; Cavazzini, F; Cerrano, M; Chiara, E; Crugnola, M; Galimberti, S; Gambacorti-Passerini, C; Iuliano, F; Iurlo, A; Levato, L; Luciano, L; Musto, P; Orlandi, E; Pregno, P; Rapezzi, D; Russo, S; Santoro, M; Sora, F; Baccarani, M; Ferrero, D; Saglio, G. |
| 6 | Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells. | 1987 | Ferrero D; Pregno P; Tarella C; Ruscetti FW; Pileri A; Gallo E. |
| 7 | Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. | 1989 | SEREMETIS S ;INGHIRAMI G ;FERRERO D ;NEWCOMB EW ;KNOWLES DM ;DOTTO GP ;DALLA-FAVERA R |
| 8 | Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. | 1989 | Seremetis S; Inghirami G; Ferrero D; Newcomb EW; Knowles DM; Dotto GP; Dalla-Favera R. |
| 9 | The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation | 2007 | Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella |
| 10 | Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation. | 1982 | FERRERO D; C. TARELLA; GALLO E; RUSCETTI FW; BREITMAN TR |
| 11 | Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment. | 2012 | Lobetti-Bodoni C; Ferrero D; Genuardi E; Passera R; Bernocco E; Sia D; Grignani G; Crisà E; Monitillo L; Rocci A; Drandi D; Giai V; Zanni M; Boi M; Isaia G; Barbero D; Lunghi M; Abruzzese E; Radaelli F; Pini M; Pregno P; Carlo-Stella C; Gaidano G; Boccadoro M; Ladetto M. |
| 12 | Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines | 2004 | Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella |
| 13 | Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. | 2014 | Ferrero D;Crisà E;Marmont F;Audisio E;Frairia C;Giai V;Gatti T;Festuccia M;Bruno B;Riera L;Passera R;Boccadoro M |
| 14 | Surface phenotypes of human hemopoietic progenitor cells defined by monoclonal antibodies. | 1985 | FERRERO D ;GABBIANELLI M ;PESCHLE C ;LANGE B ;ROVERA G |
| 15 | Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies. | 1984 | Lange B; Ferrero D; Pessano S; Palumbo A; Faust J; Meo P; Rovera G |
| 16 | Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: modulating effects of dihydroxylated vitamin D3, alpha interferon and 'stem cell factor'. | 1997 | FERRERO D ;CARLESSO N ;BRESSO P ;ROUX V ;PREGNO P ;GALLO E ;PILERI A |
| 17 | Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies. | 1984 | Pessano S; Palumbo A; Ferrero D; Pagliardi GL; Bottero L; Kai Lai S; Meo P; Carter C; Hubbel H; Lange B; Rovera G |
| 18 | Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. | 1994 | V. PIACIBELLO; F. SANAVIO; P. BRESSO; A. SEVERINO; N. CARLESSO; P. PREGNO; A. STACCHINI; S. MORELLI; L. FUBINI; E. GALLO; M. AGLIETTA; D. FERRERO |
| 19 | Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes | 2003 | CILLONI D; GOTTARDI E; MESSA F; FAVA M; SCARAVAGLIO P; BERTINI M; GIROTTO; M; MARINONE C; FERRERO D; GALLAMINI A; LEVIS A; G. SAGLIO |
| 20 | Sensibilita' delle sottopopolazioni staminali mieloidi (CFU-GM) a CSA di diversa origine. | 1985 | Gallo E; Ferrero D; Badoni R; Caracciolo D; Bellone G; Tarella C. |
Nome completo:
FERRERO, Dario
Varianti:
Ferrero D.
D. Ferrero
Dario Ferrero
D. Ferrero
Dario Ferrero
Copyright © 2019